Clinical Trial

Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

Name: Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2 — clinical trial record (NCT06997003)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Prospective, post market clinical follow up study with a three months postoperative follow up to evaluate the visual and refractive outcomes of OCTAVIUS treatment when used as intended.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-05-21; most recent amendment 2025-06-19.

Trial Details

NCT Number	NCT06997003
Lead Sponsor	Bausch & Lomb GmbH
Conditions	Hyperopia and Myopia
Enrollment	81 participants
Start Date	2025-06-16
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2025-06-22